Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
CALL
Texas Instruments
TXN
$257B
| $202M | 0.05% |
1,313,500
-74,100
| -5% | -$12.5M |
|
277
CALL
ConocoPhillips
COP
$151B
| $201M | 0.05% |
2,242,700
+477,200
| +27% | +$49.2M |
|
278
CALL
Domino's
DPZ
$11.8B
| $200M | 0.05% |
514,400
+48,900
| +11% | +$18.1M |
|
279
PUT
Intuit
INTU
$92B
| $200M | 0.05% |
518,100
+10,100
| +2% | +$4.18M |
|
280
Merck
MRK
$322B
| $197M | 0.05% |
2,155,490
-1,233,115
| -36% | -$109M |
|
281
CALL
JD.com
JD
$43.1B
| $196M | 0.05% |
3,053,300
-594,700
| -16% | -$34.3M |
|
282
CALL
Comcast
CMCSA
$91B
| $196M | 0.05% |
4,995,300
-430,700
| -8% | -$18.5M |
|
283
CALL
Charter Communications
CHTR
$18.8B
| $194M | 0.05% |
413,700
+91,300
| +28% | +$44.5M |
|
284
Gilead Sciences
GILD
$168B
| $193M | 0.05% |
3,126,707
+677,470
| +28% | +$41.9M |
|
|
285
PUT
Comcast
CMCSA
$91B
| $193M | 0.05% |
4,912,700
+1,323,700
| +37% | +$56.8M |
|
286
CALL
Honeywell
HON
$72.9B
| $192M | 0.05% |
1,169,965
-226,311
| -16% | -$40.6M |
|
287
CALL
Thermo Fisher Scientific
TMO
$224B
| $189M | 0.05% |
347,900
-32,200
| -8% | -$17.7M |
|
288
Occidental Petroleum
OXY
$59B
| $188M | 0.05% |
3,193,881
-151,436
| -5% | -$9.3M |
|
289
PUT
Baidu
BIDU
$35.9B
| $188M | 0.05% |
1,262,000
-799,500
| -39% | -$106M |
|
290
PUT
Union Pacific
UNP
$174B
| $187M | 0.05% |
878,900
-344,600
| -28% | -$78.4M |
|
291
Aptiv
APTV
$10.3B
| $187M | 0.05% |
2,103,624
+271,716
| +15% | +$27.7M |
|
|
292
PUT
AT&T
T
$168B
| $184M | 0.05% |
8,797,300
-1,984,826
| -18% | -$39.6M |
|
293
Regions Financial
RF
$26.9B
| $184M | 0.05% |
9,813,483
+9,569,170
| +3,917% | +$198M |
|
294
McKesson
MCK
$105B
| $184M | 0.05% |
563,474
-109,512
| -16% | -$35M |
|
295
CALL
Clorox
CLX
$13.1B
| $184M | 0.05% |
1,303,100
+825,600
| +173% | +$118M |
|
296
NextEra Energy
NEE
$179B
| $183M | 0.05% |
2,359,518
+1,257,042
| +114% | +$95.7M |
|
297
Cytokinetics
CYTK
$10.6B
| $182M | 0.05% |
4,642,827
+4,370,177
| +1,603% | +$176M |
|
298
CALL
Valero Energy
VLO
$93.3B
| $182M | 0.05% |
1,711,100
+908,100
| +113% | +$107M |
|
299
PUT
Pinduoduo
PDD
$129B
| $181M | 0.05% |
2,929,700
-931,400
| -24% | -$43.6M |
|
300
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
| $181M | 0.05% |
1,410,100
+94,100
| +7% | +$12.3M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.